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ACL: anterior cruciate ligament 
BMI: body mass index 
CON: control group 
ECM: extracellular matrix 
EDTA: ethylenediaminetetraacetic acid 
HWE: Hardy?Weinberg equilibrium 
KDR: kinase insert?domain receptor 
LD: linkage disequilibrium 
RFLP: restriction fragment length polymorphism 
PCR: polymerase chain reaction 
SA: South Africa 
SNP: single nucleotide polymorphism 
TEN: Achilles tendinopathy 
UK: United Kingdom 
VEGFA: vascular endothelial growth factor, A isoform 
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	
Sport and Exercise Medicine is one of the important subspecialties of 21
st
 century healthcare 
contributing to improving the physical function, health and vitality of populations while 
reducing the prevalence of lifestyle?related diseases. Moreover, sport and exercise are 
associated with injuries such as Achilles tendinopathy, a common tendon injury. The 
angiogenesis?associated signalling pathway plays a key role in extracellular matrix 
remodelling, with increased levels of angiogenic cytokines reported after cyclic stretching of 
tendon fibroblasts. We investigated the variants in angiogenesis genes in relation to the risk 
of Achilles tendinopathy in two population samples drawn independently from South Africa 
(SA) and United Kingdom (UK). The study sample was comprised of 120 SA and 130 UK 
healthy controls, and 108 SA and 87 UK participants with Achilles tendinopathy. All 
participants were genotyped for five functional polymorphisms in the vascular endothelial 
growth factor (+) (rs699947, rs1570360, rs2010963) and kinase insert?domain receptor 
(,-) genes (rs1870377, rs2071559). The + A?G?G inferred haplotype was associated 
with an increased risk of Achilles tendinopathy in the SA group (15% in controls versus 20% 
in cases, p=0.048) and the combined SA+UK group (14% in controls versus 20% in cases, 
p=0.009). These new findings implicate the + gene with Achilles tendinopathy risk, 
while highlighting the potential biological significance of the angiogenesis signalling 
pathway in the aetiology of Achilles tendinopathy. The evidence suggesting a genetic 
contribution to the susceptibility of sustaining a tendon injury is growing. We anticipate that 
high?throughput and multi?omics approaches, building on genomics, proteomics and 
metabolomics, may soon uncover the pathophysiology of many diseases in the field of Sports 
and Exercise Medicine, as a new frontier of global precision medicine.  
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Sport and Exercise Medicine is one of the important subspecialties of 21
st
 century 
healthcare contributing to improving the physical function, health and vitality of the 
population and working together with other disciplines to counter the increasing prevalence 
of chronic lifestyle?related disease. However, Sport and Exercise Medicine has not received 
the commensurate attention it deserves in the field of human genetics and the next generation 
omics technology applications. In this context, Achilles tendinopathy, one of the common 
soft tissue injuries, is amenable to research using modern genetics approaches. Tendon 
injuries constitute approximately 30?50% of all sporting injuries (Järvinen et al., 2005), with 
annual incidence rates of Achilles tendinopathy reported to be between 7?9% for top?level 
runners (Hirschmüller et al., 2012). 
The underlying biological pathways and molecular mechanisms culminating in acute 
and overuse injuries are currently under investigation in an effort to improve both preventive 
and treatment modalities. To date, several intrinsic factors, including genetics, have been 
identified as risk factors predisposing an individual to musculoskeletal soft tissue injuries 
(Collins and Raleigh, 2009; Meeuwisse, 1994; Posthumus et al., 2011). The results of 
genetic?association studies, along with histopathological examination and expression studies, 
have assisted in elucidating some of the key biological pathways that may potentially be 
involved in the aetiology of musculoskeletal soft tissue injuries (Collins et al., 2015; Riley, 
2008; Xu and Murrell, 2008). 
Tendons are metabolically active tissues and are able to respond to stimuli but the rate 
of metabolism is slow (O’Brien, 1997). It is possible that the metabolic rate may increase in 
response to mechanical loading to allow for remodelling of the extracellular matrix (ECM) 
(Wang, 2006). Evidence shows that mechanical stimuli causes an increase in the expression 
of several cell signalling molecules (Jiang et al., 2012; Legerlotz et al., 2012; Skutek et al., 
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2001). In particular, a number of studies have reported a pro?angiogenic expression profile 
after cyclic strain of tenocytes (Mousavizadeh et al., 2014; Nakama et al., 2006; Petersen et 
al., 2004) and during remodelling (Petersen et al., 2003). Moreover, an increase in vascularity 
was observed after mechanical loading and in symptomatic Achilles tendons (Lewis et al., 
2009; Molloy et al., 2003; Pufe et al., 2001; Scott et al., 2008) whereas normal healthy 
tendons are relatively avascular structures (Pufe et al., 2001). A number of cell signalling 
molecules function in the angiogenesis pathway, such as transforming growth factor?β and 
fibroblast growth factor, with vascular endothelial growth factor (VEGF) considered to be a 
critical regulator of angiogenesis.  
The + gene codes for the A isoform of the protein. This potent angiogenic factor 
is able to function in a diverse range of signalling pathways (Evans, 2015), and expression 
levels may be induced by mechanical loading, hypoxia as well as a number of biochemical 
factors/molecules (Neufeld et al., 1999; Petersen, Pufe, et al., 2003). Although, healthy 
tendons display negligible amounts of VEGF, this increases significantly during remodelling 
(Mousavizadeh et al., 2014; Petersen et al., 2004; Pufe et al., 2001). Furthermore, expression 
levels of VEGF in degenerative tendons are comparable to foetal tendons (Legerlotz et al., 
2012; Pufe et al., 2001). VEGF binds to one of two high?affinity receptors, Flt?1 (fms related 
tyrosine kinase 1) or KDR (kinase insert?domain receptor), localised on the cell surfaces of 
vascular endothelial cells. KDR, encoded by the ,- gene, is considered the major mediator 
of the angiogenic, mitogenic, and permeability?enhancing effects of VEGF (Bao et al., 2009; 
Ferrara et al., 2003) both in normal physiology and in pathological processes (Ferrara et al., 
2003).  
Recently, genetic variants within the + and ,- genes were associated with risk 
of anterior cruciate ligament (ACL) ruptures (Rahim et al., 2014). Specifically, independent 
associations as well as haplotype combinations were implicated, thereby suggesting genomic 
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intervals harbouring potential DNA motifs within these two genes (Rahim et al., 2014). The 
aim of this study was to investigate the previously associated functional + rs699947, 
rs1570360, rs2010963 and ,- rs1870377 and rs2071559 variants with risk of Achilles 
tendinopathy in a South African and a British population.  
!	
	
"	

	
		
A total of 120 physically active South African Caucasian asymptomatic control (SA 
CON group) participants and 87 participants with chronic Achilles tendinopathy (SA TEN) 
were included in this study. These samples were previously recruited (2004?2013), according 
to the inclusion and exclusion criteria described by Mokone et al. (Mokone et al., 2005, 
2006). In addition, a previously recruited (2011?2014) British Caucasian study group 
(Rickaby et al., 2015) consisting of 130 asymptomatic controls (UK CON group) and 108 
participants with chronic Achilles tendinopathy (UK TEN) was included. The participants 
from each population were matched for country of birth (self?reported) and provided written 
informed consent. Furthermore, each participant completed questionnaires specifying 
personal details, injury details and medical and sporting history. For the cases, age was 
recorded at time of injury and for the controls at time of recruitment.  
This study was approved by the Faculty of Health Sciences Research Ethics Committee 
within the University of Cape Town, South Africa and the Research Ethics Committee of the 
University of Northampton. This case?control genetic association study is in accordance with 
the recommendations of the STREGA Statement for reporting the results of genetic 
association studies (Little et al., 2009).
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#$		

For the South African participants, approximately 5ml of venous blood was collected 
from each patient by venipuncture of the forearm vein, into an EDTA Vacutainer
®
 tube. 
Samples were stored at ?20°C prior to total DNA extraction using the standard protocol as 
described by Lahiri and Nurnberger (1991)
  
with slight modifications (Mokone et al., 2006). 
For the British participants, 2ml of saliva was obtained from each participant for DNA 
extraction as previously described (Rickaby et al., 2015). DNA extractions were performed at 
the University of Northampton and the samples made available for this study.  
%$"	
	

The five single nucleotide polymorphisms (SNPs) selected for analysis within the 
+ (rs699947, rs1570360, rs2010963) and ,- (rs1870377 and rs2071559) genes were 
previously implicated with risk of anterior cruciate ligament ruptures (Rahim et al., 2014). 
All samples (SA group n=273 and UK group n=242) were genotyped for the five 
polymorphisms using standard genotyping protocols. Polymerase chain reaction (PCR) and 
restriction fragment length polymorphism (RFLP) analysis was used for the + 
rs699947 (#.II) (Garza?Veloz et al., 2011) and ,- rs1870377 (*I) SNPs. Details of the 
primers sequences and PCR conditions are available on request. Restriction fragments were 
resolved, together with a 100bp size standard, by 2% agarose gel electrophoresis. Catalogued 
TaqMan™ Genotyping Assays (Applied Biosystems, Foster City, California, USA) were 
used for the + rs1570360, + rs2010963 and ,- rs2071559 SNPs. The PCR 
reactions were conducted using the Applied Biosystems StepOnePlus™ Real?Time PCR 
system and the Applied Biosystems StepOnePlus™ Real?Time PCR software v2.2.2 (Applied 
Biosystems), following manufacturer’s recommendations.  
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Every PCR plate (RFLP and TaqMan™ analyses) contained negative controls (no 
DNA) and five repeat samples (known genotypes) as a quality control measure for reliable 
genotyping and detection of contamination. Genotypes were confirmed by two independent 
investigators, with an average genotyping success rate of 95%. Samples that failed twice to 
amplify during PCR for a particular SNP were considered unsuccessfully genotyped. (Rahim 
et al., 2014)All genotyping was conducted at the Division of Exercise Science & Sports 
Medicine within the University of Cape Town. 
%		
	


Power calculations were calculated using QUANTO v1.2.4 (http://hydra.usc.edu/gxe) 
to determine sample size for the study. Assuming minor allele frequencies between 0.2 and 
0.5, a sample size of 85 cases would be adequate to detect an allelic odds ratio (OR) of 2.0 
and greater at a power of 80% and a significance level of 5%. The programming environment 
R (R Development Core Team, 2010) was used for all data analysis. Basic descriptive 
statistics were compared using one?way analysis of variance to determine any significant 
differences between the characteristics of the CON vs. TEN groups. The R packages . 
(Warnes et al., 2011) and '	 (González et al., 2007) were used to analyse any 
differences in genotype and allele frequencies between the diagnostic groups (CON/TEN) 
and to calculate Hardy?Weinberg equilibrium probabilities and linkage disequilibrium. 
Haplotypes were inferred using the R package 	 (Schaid et al., 2002; Sinnwell and 
Schaid, 2011). Analysis of the participant characteristics revealed potential confounding 
variables so for this reason the genotype and haplotype analyses were adjusted accordingly. 
In addition to the analyses within the SA and UK study groups, the genotype and allele 
frequency distributions were compared between the countries (SA/UK), adjusting for age, 
weight and diagnostic group and in the combined (SA+UK) groups, adjusting for age, weight 
and country. Statistical significance was accepted when p<0.05. No adjustments were made 
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for multiple testing as currently no obvious appropriate method exists (Nyholt, 2004; 
Perneger, 1998). The Bonferroni correction was considered too conservative for this study, as 
the tests are on the same group of participants and several of the polymorphisms were in tight 
linkage disequilibrium (Nyholt, 2004). Furthermore, correction for multiple testing was 
considered inappropriate as there was an 	 hypothesis (Perneger, 1998; Posthumus et 
al., 2012) 
	
"	

		
	

The participant characteristics for the SA and UK groups were previously described in 
earlier studies investigating the same study participants (Mokone et al., 2005, 2006; Rickaby 
et al., 2015). Briefly, the SA CON and SA TEN participants were unmatched for age, weight 
and BMI (Table 1). In the UK study group, the CON and TEN participants were matched for 
all characteristics except age (Table 2). There were no significant genotype effects on age, 
sex, height, weight or BMI for any of the polymorphisms (Table S1).   
&	'

The + rs699947 genotype frequency was significantly different (p=0.003) 
between the SA CON and SA TEN groups (Table 3). The CC genotype was significantly 
over?represented in the SA CON group (32%, n=35) compared to the SA TEN group (17%, 
n=14) (p=0.019, OR: 2.30, 95% CI: 1.14?4.64). Additionally, the CA genotype was 
significantly under?represented in the SA CON group (40%, n=43) compared to the SA TEN 
group (60%, n=49) (p=0.005, OR: 2.32, 95% CI: 1.28?4.17). No other significant differences 
in genotype or allele frequency distributions were observed between the CON and TEN 
groups (Table 3) for any of the five polymorphisms investigated in either the South African 
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or the British participants. The genotype and minor allele frequency distributions were 
similar to those reported for other European populations (http://www.ncbi.nlm.nih.gov/snp/) 
and for the previous ACL study by our group (Rahim et al., 2014). All the groups were in 
HWE except for the UK TEN group for the rs1570360 SNP (p=0.020) and the rs1870377 
SNP (p=0.015). 
Comparisons in genotype and allele frequency distributions between the countries, 
showed only the ,- rs2071559 genotype frequency distribution was significantly different 
between the groups (p=0.026) (Table 3). When the SA+UK groups were combined no 
significant differences were observed in genotype or allele frequency distribution (Table 3). 
The linkage disequilibrium (LD) structure of the investigated SNPs within the + gene, 
is presented in the supplementary material (Fig S1). 
 	
Of the eight possible haplotype combinations constructed from the + variants 
(rs699947 C/A – rs1570360 G/A – rs2010963 G/C), only four (C?G?G, C?G?C, A?G?G, A?A?
G) were inferred at a frequency greater than 2%. The A?G?G inferred haplotype combination 
was significantly under?represented (Fig. 1A) in the SA CON group (15%, n=18) vs. the SA 
TEN group (20%, n=22) (dominant model, p=0.048; haplo.score:1.97). Similarly, when the 
SA and UK groups were combined the A?G?G haplotype was significantly under?represented 
in the SA+UK CON group (14%, n=35) vs. the SA+UK TEN group (20%, n=39) (dominant 
model, p=0.009; haplo.score:2.61) (Fig. 1C). However, no significant differences were 
observed between the UK CON and UK TEN groups (Fig. 1B).  
Haplotypes were also inferred for the rs2071559 A/G and rs1870377 T/A 
polymorphisms within the ,- gene but no significant differences in frequency distribution 
were observed between any of the groups after adjusting for the potential confounders (data 
not shown).  
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#


The angiogenesis?associated signalling pathway is considered a key biological mediator 
to promote matrix remodelling. Therefore, this study investigated five polymorphisms within 
the + (rs699947, rs1570360 and rs2010963) and ,- (rs2071559 and rs1870377) 
genes with risk of Achilles tendinopathy in two independent populations. The main finding of 
this paper was the haplotype association of the three + SNPs with risk of TEN in the 
SA group and the combined SA+UK group.  
Vascular endothelial growth factor is a potent angiogenic factor, with a key role in the 
formation of new vasculature (Ferrara et al., 2003). The importance of VEGF in 
vasculogenesis and angiogenesis was demonstrated by Carmeliet et al. using a mouse gene 
knockout model, where loss of a single + allele led to embryonic lethality (Carmeliet et 
al., 1996). Consequently, an abundance of research has focused on the role of this growth 
factor in normal physiology, pathological conditions and as a part of therapeutic strategies. 
To date, VEGF has been implicated in several pathological conditions including cancer, 
macular degeneration and rheumatoid arthritis (Evans, 2015). It is hypothesised that 
angiogenesis also occurs after mechanical loading in an effort to promote remodelling of the 
tendon extracellular matrix. This is further supported by studies identifying increased VEGF 
levels after mechanical loading of tenocytes (Mousavizadeh et al., 2014; Nakama et al., 2006; 
Petersen et al., 2004).  
In the present study, the + A?G?G (rs699947 C/A – rs1570360 G/A – rs2010963 
G/C) inferred haplotype was associated with increased risk of TEN. This association was 
noted in both the SA and the combined SA+UK groups which provides further support 
implicating the + locus in modulating musculoskeletal injury susceptibility (Rahim et 
al., 2014). The + A?G?G haplotype combination is associated with decreased 
transcription of the + gene and reduced VEGF plasma levels (Lambrechts et al., 2003). 
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Hence it is possible that angiogenesis is limited in an already hypovascular structure thus 
restricting the extent of matrix remodelling that is able to occur. Tang et al. (2016) 
hypothesised that low VEGF activity may be partly responsible for the slow or weak healing 
capacity of injured tendons. Furthermore, the authors demonstrated that VEGF gene therapy 
via an adeno?associated viral type?2 (AAV2) vector resulted in marked improvements in 
tendon healing and remodelling in an animal model (Tang et al., 2016). Taken collectively, 
investigation into the role of VEGF in modulating both tendon capacity and injury 
susceptibility is warranted. 
A recent study implicated the A?A?G inferred haplotype, with decreased risk of non?
contact ACL ruptures (Rahim et al., 2014). The explanation for the contrasting haplotype 
associations observed between TEN and ACL ruptures is not completely understood. It is 
interesting to note that both these implicated haplotypes are associated with reduced VEGF 
plasma levels (Lambrechts et al., 2003). One could therefore hypothesise that because the 
vascularity of tendons and ligaments differ (Benjamin et al., 2006; Fenwick et al., 2002), the 
biological impact of low levels of VEGF on neovascularisation related to remodelling and 
capacity would potentially be different between these functionally different tissues. 
Alternatively, the results may be indicating that these polymorphisms are potentially in 
linkage with a true risk variant. Thus, it is key that these genomic regions are further 
explored. Specifically, these associations need to be investigated at a functional level to 
determine the biological significance of these variants, and of angiogenesis in the repair 
model for TEN and ACL ruptures.  
It is not surprising that the haplotype implicated in TEN risk modulation is reflected in 
the independent association of the rs699947 SNP genotype in the South African study group. 
Moreover, this promoter (?2578C/A) polymorphism is known to be functional, with the C 
allele correlating to increased VEGF protein production, and the AA genotype linked with 
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lower transcriptional activity (Shahbazi et al., 2002) and increased risk in several phenotypes 
(Andraweera et al., 2012; Lambrechts et al., 2009; Seo et al., 2005). Therefore, there is 
evidence implicating the + gene locus and specific variants at a functional and genetic 
level with risk modulation.  
Although, no independent or haplotype associations were observed for the ,- gene, 
this remains a viable candidate for further investigation particularly due to its importance in 
the VEGF signalling pathway. KDR is one of two main receptors that VEGFA binds to and is 
responsible for the main downstream signalling effects of the ligand (Ferrara et al., 2003). 
Moreover, ,- null mutant mice were observed to be embryonically lethal (Shalaby et al., 
1995). Therefore, it may be worth exploring additional genomic loci within this candidate 
gene as the two polymorphisms (rs2071559 and rs1870377) investigated in the current study 
are situated in the promoter and exon 11, respectively.  
A limitation of the study was that SA participants were not matched for age, weight or 
BMI. We were unable to determine the weight at time of injury for the cases due to 
incomplete data but several participants reported an increase in weight due to injury?related 
inactivity. Additionally, the older age of the cases may have influenced the weight of the 
cases. In the UK participants, the CON and TEN groups were also unmatched for age and for 
this reason, all statistical analyses were adjusted for the confounders. Although, the UK TEN 
group deviated from HWE at the rs1570360 and rs1870377 loci, the genotype and minor 
allele frequency distributions were similar to those reported for other European populations. 
The main limitation of this study was the small sample size and therefore the SA and UK 
study groups were also combined for the statistical analyses. A minimum sample size of 85 
cases was adequate to detect only allelic odds ratios of 2.0 and greater, whereas the combined 
SA+UK group sample set was sufficient to detect allelic odds ratios of 1.6 and greater. 
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(

Our observations collectively suggest that a genomic interval within the + gene 
was associated with risk of TEN. This gene requires further exploration to understand the 
potential role of + and specifically angiogenesis in the aetiology of TEN. Investigation 
into genes involved in the angiogenesis?associated signalling pathway may aid in the 
development of a risk profile for tendinopathy. In line with this, our future work is aiming 
towards employing next?generation technologies, specifically whole exome sequencing, to 
further explore these regions of interest in an effort to further characterise these genomic 
signatures.  
The era of “	 / is becoming a large focus underpinning research 
(Poland et al. 2011; Higdon et al. 2015). The technologies of the 	 era has revolutionised 
our capacity to unravel these complex phenotypes. Through Big Data emerging from multi?
omics research streams at genomics, proteomics, transcriptomics, epigenomics and 
bioinformatics levels we can advance the depth and breadth of research in the field of Sports 
and Exercise Medicine, with a view to improving global health, preventive medicine and 
quality of life.  
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sequence variations (not included in this manuscript) related to risk assessment of anterior 
cruciate ligament ruptures and Achilles tendinopathy. 
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